144: Filer Information

Filer CIK

0001533098

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Medtronic plc

SEC File Number

001-36820

Address of Issuer

BUILDING TWO PARKMORE BUSINESS PARK WEST
GALWAY
IRELAND
H91 4K49

Phone

01135314381700

Name of Person for Whose Account the Securities are To Be Sold

Smith Gregory L

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Officer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Fidelity Brokerage Services LLC
900 Salem Street
Smithfield � RI � 02917

30000

3058452.26

1282685882

11/19/2025

NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

06/30/2022

ESPP Purchase

Issuer

06/30/2022

Cash

Common

09/30/2022

ESPP Purchase

Issuer

123

09/30/2022

Cash

Common

03/31/2023

ESPP Purchase

Issuer

103

03/31/2023

Cash

Common

04/05/2023

Restricted Stock Vesting

Issuer

10620

04/05/2023

Compensation

Common

04/14/2023

Restricted Stock Vesting

Issuer

04/14/2023

Compensation

Common

06/30/2023

ESPP Purchase

Issuer

06/30/2023

Cash

Common

09/29/2023

ESPP Purchase

Issuer

106

09/29/2023

Cash

Common

12/29/2023

ESPP Purchase

Issuer

12/29/2023

Cash

Common

03/28/2024

ESPP Purchase

Issuer

03/28/2024

Cash

Common

06/28/2024

ESPP Purchase

Issuer

06/28/2024

Cash

Common

07/31/2024

Restricted Stock Vesting

Issuer

3018

07/31/2024

Compensation

Common

08/02/2024

Restricted Stock Vesting

Issuer

4446

08/02/2024

Compensation

Common

09/30/2024

ESPP Purchase

Issuer

107

09/30/2024

Cash

Common

07/31/2025

Restricted Stock Vesting

Issuer

2942

07/31/2025

Compensation

Common

08/01/2025

Restricted Stock Vesting

Issuer

8075

08/01/2025

Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

11/19/2025

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gregory L. Smith.

144: Filer Information

Submission Contact Information

144: Issuer Information

144: Securities Information

144: Securities To Be Sold

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

ATTENTION:

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

SEC Form 144 filed by Medtronic plc.